Graham Capital Management’s Replimune Group REPL Stock Holding History

Graham Capital Management’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$195K	Buy	25,444 +11,087	+77%	+$84.8K	﹤0.01%	959
2025 Q4	$140K	Sell	14,357 -30,340	-68%	-$258K	﹤0.01%	1111
2025 Q3	$187K	Buy	+44,697	New	+$286K	﹤0.01%	1073
2025 Q2	–	Sell	-38,118	Closed	-$372K	–	1566
2025 Q1	$372K	Buy	38,118 +7,938	+26%	+$98.2K	0.01%	918
2024 Q4	$365K	Buy	30,180 +1,731	+6%	+$21K	0.01%	852
2024 Q3	$312K	Buy	28,449 +5,824	+26%	+$59.2K	0.01%	768
2024 Q2	$204K	Sell	22,625 -68,512	-75%	-$478K	﹤0.01%	861
2024 Q1	$745K	Buy	91,137 +40,962	+82%	+$336K	0.01%	505
2023 Q4	$423K	Buy	50,175 +30,308	+153%	+$351K	0.01%	638
2023 Q3	$340K	Buy	+19,867	New	+$390K	0.01%	682
2022 Q2	–	Sell	-21,200	Closed	-$359K	–	1204
2022 Q1	$359K	Buy	+21,200	New	+$400K	0.01%	669

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Graham Capital Management's REPL Position: Q1 2026 in Review

Graham Capital Management increased its Replimune Group (REPL) stake by 77% in Q1 2026, buying an estimated $84.8K and bringing the position to 25,444 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #959.

Graham Capital Management first reported a position in REPL in Q1 2022 and has held it in 11 quarters since. The position peaked at $745K in Q1 2024. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

Graham Capital Management held 25,444 shares of Replimune Group worth $195K as of Q1 2026.
Graham Capital Management bought 11,087 Replimune Group shares in Q1 2026, an estimated $84.8K.
Replimune Group made up ﹤0.01% of Graham Capital Management's portfolio in Q1 2026, its #959 holding.
Graham Capital Management first reported a position in Replimune Group in Q1 2022 and has held it in 11 quarters since.
Graham Capital Management's Replimune Group position peaked at $745K in Q1 2024.
180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.